Follow up of Nasolacrimal Intubation in Adults
Long Term Follow up of Nasolacrimal Intubation in Adults With Mild Epiphora
1 other identifier
observational
180
1 country
1
Brief Summary
For patients with chronic epiphora, Dacryocystorhinostomy is currently the gold standard treatment, with a success rate of 80-90% according to literature. Another available treatment, which is far less used, in nasolacrimal intubation, using a silicone tube. In our study, we would like to find the efficacy of nasolacrimal duct intubation, which was performed in our medical center on a few hundred patients with mild epiphora. Study hypothesis: nasolacrimal intubation in adults, with a clinically mild epiphora, is close in it's efficacy to the Dacryocystorhinostomy procedure.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2000
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2007
CompletedFirst Submitted
Initial submission to the registry
June 26, 2008
CompletedFirst Posted
Study publicly available on registry
June 27, 2008
CompletedJune 27, 2008
June 1, 2008
7.9 years
June 26, 2008
June 26, 2008
Conditions
Outcome Measures
Primary Outcomes (1)
Patient being completely free of tearing.
1 year.
Secondary Outcomes (1)
Following nasolacrimal intubation, did the patient need a Dacryocystorhinostomy surgery.
1 year
Study Arms (1)
Primary
All the patients in our medical center who underwent nasolacrimal intubation, due to mild epiphora, during the years 2000-2007.
Interventions
Silicone tube which is inserted into the tear duct through the punctum in the eyelid, then passed through the tear duct till it enters the nose and secured in place using a surgical knot. The tube remains in place for 3-6 months, than take out by the surgeon.
Eligibility Criteria
Patient who underwent nasolacrimal intubation in Maccabi Healthcare, due to mild epiphora, during the years 2000-2007.
You may qualify if:
- Clinical diagnosis of mild epiphora.
- Underwent nasolacrimal intubation during 01/2000 - 12/2007.
You may not qualify if:
- Purulent excretions from nasolacrimal duct on day of admission or intubation.
- Nasolacrimal intubation in the past.
- Dacryocystorhinostomy in the past.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Maccabi Healthcare Eye Clinic
Tel Aviv, Israel
Related Publications (7)
Becker BB, Berry FD, Koller H. Balloon catheter dilatation for treatment of congenital nasolacrimal duct obstruction. Am J Ophthalmol. 1996 Mar;121(3):304-9. doi: 10.1016/s0002-9394(14)70279-x.
PMID: 8597274BACKGROUNDHurwitz JJ, Rutherford S. Computerized survey of lacrimal surgery patients. Ophthalmology. 1986 Jan;93(1):14-9. doi: 10.1016/s0161-6420(86)33779-5.
PMID: 3951812BACKGROUNDKeith CG. Intubation of the lacrimal passages. Am J Ophthalmol. 1968 Jan;65(1):70-4. doi: 10.1016/0002-9394(68)91031-3. No abstract available.
PMID: 5635571BACKGROUNDQuickert MH, Dryden RM. Probes for intubation in lacrimal drainage. Trans Am Acad Ophthalmol Otolaryngol. 1970 Mar-Apr;74(2):431-3. No abstract available.
PMID: 5445947BACKGROUNDCrawford JS. Intubation of obstructions in the lacrimal system. Can J Ophthalmol. 1977 Oct;12(4):289-92.
PMID: 922571BACKGROUNDPashby RC, Rathbun JE. Silicone tube intubation of the lacrimal drainage system. Arch Ophthalmol. 1979 Jul;97(7):1318-22. doi: 10.1001/archopht.1979.01020020060014.
PMID: 454271BACKGROUNDConnell PP, Fulcher TP, Chacko E, O' Connor MJ, Moriarty P. Long term follow up of nasolacrimal intubation in adults. Br J Ophthalmol. 2006 Apr;90(4):435-6. doi: 10.1136/bjo.2005.084590.
PMID: 16547322BACKGROUND
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY DIRECTOR
Arie Nemet, MD
Shaare Zedek Medical Center, Maccabi Healthcare
- STUDY CHAIR
Arie Nemet, MD
Shaare Zedek Medical Center, Maccabi Healthcare
- PRINCIPAL INVESTIGATOR
Arie Nemet, MD
Shaare Zedek Medical Center, Maccabi Healthcare
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
June 26, 2008
First Posted
June 27, 2008
Study Start
January 1, 2000
Primary Completion
December 1, 2007
Last Updated
June 27, 2008
Record last verified: 2008-06